🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07607886
Active, not recruiting Observational

Inflammatory Indices, Early Mortality, and ICU Stay in Geriatric PFN Patients

NCT07607886 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2021-01-01
Last updated
2026-05-28

Condition(s) studied

Intertrochanteric Femur FractureHip Fracture SurgeriesGeriatric Anesthesia

Study summary

This retrospective observational cohort study aims to evaluate the association between preoperative and postoperative inflammatory indices and early postoperative outcomes in geriatric patients undergoing proximal femoral nailing (PFN) for intertrochanteric femur fractures. The primary outcome of the study is 30-day mortality, while the secondary outcome is intensive care unit (ICU) length of stay. Various inflammatory biomarkers derived from routine laboratory parameters, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), immune-inflammatory prognostic index (IPI), aggregate index of systemic inflammation (AIS), and RDW-to-albumin ratio (RAR), will be analyzed to investigate their prognostic value in the acute postoperative period. The study seeks to identify simple and readily accessible biomarkers that may contribute to early risk stratification and perioperative management in elderly hip fracture patients.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients aged 65 years and older * Diagnosis of intertrochanteric femur fracture * Undergoing proximal femoral nailing (PFN) surgery * Availability of preoperative laboratory data * Availability of early postoperative laboratory measurements * Availability of 30-day mortality data * Availability of intensive care unit admission and ICU length of stay data * Complete electronic medical records Exclusion Criteria: * Patients with missing clinical or laboratory data * Pathological fractures * Multiple trauma patients * Revision surgeries * Presence of active infection or sepsis before surgery * Hematologic diseases that could affect inflammatory indices * Unavailable 30-day mortality or ICU data

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Health Sciences Gazi Yaşargil Training and Research Hospital Diyarbakır Diyarbakır

More Saglik Bilimleri Universitesi trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07607886 on ClinicalTrials.gov ↗ ← All trials in Turkey